These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6316394)

  • 21. Sertraline, a selective inhibitor of serotonin uptake, induces subsensitivity of beta-adrenoceptor system of rat brain.
    Koe BK; Koch SW; Lebel LA; Minor KW; Page MG
    Eur J Pharmacol; 1987 Sep; 141(2):187-94. PubMed ID: 2824215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase.
    Sulser F; Gillespie DD; Mishra R; Manier DH
    Ann N Y Acad Sci; 1984; 430():91-101. PubMed ID: 6331266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaprotiline: induction of central noradrenergic subsensitivity of its (+)-enantiomer.
    Mishra R; Gillespie DD; Lovell RA; Robson RD; Sulser F
    Life Sci; 1982 May; 30(20):1747-55. PubMed ID: 6285106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat.
    Kalaria RN; Harik SI
    J Neurochem; 1987 Nov; 49(5):1589-94. PubMed ID: 3117975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: effects of nisoxetine versus fluoxetine.
    Mishra R; Janowsky A; Sulser F
    Eur J Pharmacol; 1979 Dec; 60(4):379-82. PubMed ID: 316774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
    Itzhak Y; Mash D; Zhang SH; Stein I
    Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
    Dudley MW
    Life Sci; 1988; 43(23):1871-7. PubMed ID: 3143879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine.
    De Deurwaerdère P; Binda C; Corne R; Leone C; Valeri A; Valoti M; Ramsay RR; Fall Y; Marco-Contelles J
    ACS Chem Neurosci; 2017 May; 8(5):1026-1035. PubMed ID: 27977122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of chronic administration of inhibitors of flavin and quinone amine oxidases on imidazoline I(1) receptor density in rat whole brain.
    Holt A; Todd KG; Baker GB
    Ann N Y Acad Sci; 2003 Dec; 1009():309-22. PubMed ID: 15028605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo degradation of noradrenaline by MAO A in locus coeruleus of the rat.
    Blinc M; Dernovsek M; Sket D
    Experientia; 1989 Dec; 45(11-12):1099-102. PubMed ID: 2513220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L; Bunag RD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The serotonin/noradrenaline-link in brain. I. The role of noradrenaline and serotonin in the regulation of density and function of beta adrenoceptors and its alteration by desipramine.
    Manier DH; Gillespie DD; Sanders-Bush E; Sulser F
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):109-14. PubMed ID: 3031514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The noradrenaline receptor coupled adenylate cyclase system in brain. Lack of modification by changes in the availability of serotonin.
    Mishra R; Leith NJ; Steranka L; Sulser F
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):218-24. PubMed ID: 6265809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
    Feldman JM
    Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.